No Detail Found!

Association of vitamin d level with diabetic peripheral neuropathy

Author(s)
Marina Hidayat Department of Physiology, P.M.C. Ripha International University,Peshawar,Pakistan
Kishwar Jehandad District Health Office,District East, Karachi,Pakistan
Asia Muhammad Department of Physiology, P.M.C. Ripha International University,Peshawar,Pakistan
Zain ul Abideen Department of Physiology, Kohat Institute of Medical Science,Kohat,Pakistan
Umar Sabir Department of Stroke Medicine Norfolk and Norwich University Hospital NHS trust,Norwich,United Kingdom
Momina Haq Department of Physiology, P.M.C. Ripha International University,Peshawar,Pakistan
Abstract
Background: Diabetes mellitus causes a range of nerve damage referring to diabetic neuropathy. Diabetic peripheral neuropathy (DPN) afects over 132 million individuals worldwide (about 1.9% of the population). Diabetes is the largest recognized cause of neuropathy in afluent countries, and the most prevalent consequence and reason for morbidity and mortality. The deficient vitamin D value is one of the newest considerations of the development of diabetes and peripheral neuropathy. Objective: The objective of this study was to compare vitamin D levels among Type 2 diabetes mellitus patients with/without diabetic peripheral neuropathy and to find an association of Vitamin D levels with diabetic peripheral neuropathy based on the Michigan Neuropathy Screening Instrument (MNSI) score at a tertiary care hospital, Peshawar. Methods: A case-control study was conducted from August 2021 to October 2021 after taking approval from the ethical committee of Prime foundation Pakistan, Mercy Teaching Hospital Peshawar. Patients with type 2 diabetes were recruited and then divided into two groups using the purposive sampling technique. Type 2 diabetes with neuropathy included group A Patients (Cases), while type 2 diabetes without neuropathy included group B (Controls). Both groups had 49 study subjects each based on convenience. A physical examination was conducted to prove the diagnosis of diabetic peripheral neuropathy (DPN) using the Michigan Neuropathy Screening Instrument (MNSI). Patients screening positive on the MNSI (>2 points out of a 10-point scale) were considered neuropathic. Serum vitamin D levels were assessed in both patients (cases) and controls using a hospital laboratory and labeled as Vitamin D suficiency (more than 30ng/ml), Vitamin D deficiency (<20 ng/ml), Higher Vitamin D (100 ng/ml) and vitamin D insuficiency (between 20 and 30 ng/ml). Results: A total of 98 subjects were enrolled in the study with a 1:1 ratio of cases and controls. Median age [57 (IQR 52-65) versus 55 (IQR=48-61), p<0.001] and disease duration [10 (IQR=8-16) versus 7 (IQR=4-10), p<0.001] were significantly diferent among cases and control respectively. The proportion of patients with normal vitamin D levels was significantly lower in cases than in control (10.2% versus 67.3%, p<0.001). On the multivariable regression model, vitamin D levels were found to be an independent predictor of DPN with a significantly lower risk of DPN among patients with normal vitamin D levels as compared to those who had vitamin d higher than 100 ng/ml (OR=0.19, 95% CI:0.001-0.282, p=0.004). Conclusion: Our study concluded that patients with Type 2 diabetes mellitus DPN have deficient levels of Vitamin D as assessed by Michigan Neuropathy Screening Instrument. Considerable risk of Diabetic peripheral neuropathy among patients having a deficiency of Vitamin D was proved
Publication Details
Page(s) 26-30
Published Journal: Liaquat National Journal of Primary Care, Volume: 5, Issue: 1, Year: 2023

Request the full text from PASTIC

Keywords
Diabetes Mellitus, Vitamin D, Association, Diabetes mellitus, Diabetes mellitus, Diabetic Peripheral Neuropathy, Michigan Score
0

Citations

0

Downloads

49

Views